Alzheimer's cure still eludes
Source: Agencies |
July 13, 2010, Tuesday
|
Print Edition
Print Edition
SCIENTISTS are reporting advances in detecting and predicting Alzheimer's disease at a conference in Honolulu this week, plus offering more proof that getting enough exercise and vitamin D may lower your risk.
There are better brain scans to spot Alzheimer's disease. More genes that affect risk. Blood and spinal fluid tests that may help tell who will develop the mind-robbing illness and when.
But what is needed most - a treatment that does more than just ease symptoms - is not at hand.
"We don't have anything that slows or stops the course," said William Thies, the Alzheimer's Association scientific director. "We're really in a silent window right now" with new drugs, he said.
Several promising ones flopped in late-stage tests - most recently, Pfizer Inc's Dimebon. Results on several others won't be ready until next year.
Still, there is some progress against Alzheimer's, a dementia that afflicts more than 26 million people worldwide. Highlights of the research being reported this week:
prevention. Moderate to heavy exercisers had half the risk of developing dementia compared with less active people, researchers from the long-running Framingham Heart Study reported on Sunday. Earlier studies also found exercise helps.
Another big government-funded study found that vitamin D deficiency can raise the risk of mental impairment up to fourfold. This doesn't mean taking supplements is a good idea, doctors warn.
Novel Treatment. Tests of an insulin nose spray to improve cognition gave encouraging results, but "it's still a pilot trial" and larger studies are needed to see if this works and is safe, said Laurie Ryan. She oversees Alzheimer's study grants for the National Institute on Aging, which funded the work.
It's based on the theory that Alzheimer's and diabetes are related. Diabetics seem to have a higher risk of developing Alzheimer's, Ryan said. Giving insulin as a nose spray sends it straight to the brain without affecting blood-sugar levels, she explained.
"If it works, it would certainly be an easy thing to administer," she said.
Improved detection. Many types of imaging can document dementia, which usually is diagnosed through cognition tests. For several years, scientists have used a radioactive dye and PET scans to see the sticky brain plaque that is a key feature of Alzheimer's. But the dye is tough to use, and at least four companies are developing better ones.
Until there are better treatments, there will be little demand for tests that show you have or are destined to get the disease, several experts said.
There are better brain scans to spot Alzheimer's disease. More genes that affect risk. Blood and spinal fluid tests that may help tell who will develop the mind-robbing illness and when.
But what is needed most - a treatment that does more than just ease symptoms - is not at hand.
"We don't have anything that slows or stops the course," said William Thies, the Alzheimer's Association scientific director. "We're really in a silent window right now" with new drugs, he said.
Several promising ones flopped in late-stage tests - most recently, Pfizer Inc's Dimebon. Results on several others won't be ready until next year.
Still, there is some progress against Alzheimer's, a dementia that afflicts more than 26 million people worldwide. Highlights of the research being reported this week:
prevention. Moderate to heavy exercisers had half the risk of developing dementia compared with less active people, researchers from the long-running Framingham Heart Study reported on Sunday. Earlier studies also found exercise helps.
Another big government-funded study found that vitamin D deficiency can raise the risk of mental impairment up to fourfold. This doesn't mean taking supplements is a good idea, doctors warn.
Novel Treatment. Tests of an insulin nose spray to improve cognition gave encouraging results, but "it's still a pilot trial" and larger studies are needed to see if this works and is safe, said Laurie Ryan. She oversees Alzheimer's study grants for the National Institute on Aging, which funded the work.
It's based on the theory that Alzheimer's and diabetes are related. Diabetics seem to have a higher risk of developing Alzheimer's, Ryan said. Giving insulin as a nose spray sends it straight to the brain without affecting blood-sugar levels, she explained.
"If it works, it would certainly be an easy thing to administer," she said.
Improved detection. Many types of imaging can document dementia, which usually is diagnosed through cognition tests. For several years, scientists have used a radioactive dye and PET scans to see the sticky brain plaque that is a key feature of Alzheimer's. But the dye is tough to use, and at least four companies are developing better ones.
Until there are better treatments, there will be little demand for tests that show you have or are destined to get the disease, several experts said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
